CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $416,000 | -31.8% | 35,714 | -28.6% | 0.06% | -40.2% |
| Q1 2021 | $610,000 | -51.2% | 50,000 | -50.0% | 0.10% | -80.1% |
| Q4 2020 | $1,251,000 | +3.9% | 100,014 | +25.0% | 0.51% | -17.3% |
| Q3 2020 | $1,204,000 | +176.1% | 80,000 | +349.4% | 0.62% | +166.8% |
| Q2 2020 | $436,000 | -20.6% | 17,800 | -54.0% | 0.23% | -23.4% |
| Q1 2020 | $549,000 | -7.7% | 38,670 | +3.1% | 0.30% | +27.8% |
| Q4 2019 | $595,000 | +66.2% | 37,500 | -11.8% | 0.24% | +39.4% |
| Q3 2019 | $358,000 | -19.9% | 42,505 | -14.5% | 0.17% | -16.7% |
| Q2 2019 | $447,000 | – | 49,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |